James Douketis, MD
Douketis J.; Rivaroxaban was noninferior to enoxaparin for preventing short-term recurrent VTE and superior to placebo in continued treatment. Ann Intern Med. 2011;154:JC5-6. doi: 10.7326/0003-4819-154-10-201105170-02006
Download citation file:
Published: Ann Intern Med. 2011;154(10):JC5-6.
to gain full access to the content and tools.
Learn more about subscription options.
Register Now for a free account.
Results provided by:
Copyright © 2016 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only